Hamman-Rich syndrome classification: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 32: Line 32:


==Classification==
==Classification==
*According to American Thoracic Society/European Respiratory Society (ATS/ERS) 2002 consensus, Acute interstitial pneumonitis is a variant of a group of Idiopathic interstitial lung diseases.<ref name="pmid11790668">{{cite journal |vauthors= |title=American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001 |journal=Am. J. Respir. Crit. Care Med. |volume=165 |issue=2 |pages=277–304 |date=January 2002 |pmid=11790668 |doi=10.1164/ajrccm.165.2.ats01 |url=}}</ref>
*According to American Thoracic Society/European Respiratory Society (ATS/ERS) 2002 consensus, [[Hamman-Rich syndrome|Acute interstitial pneumonitis]] is a variant of a group of Idiopathic interstitial lung diseases.<ref name="pmid11790668">{{cite journal |vauthors= |title=American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001 |journal=Am. J. Respir. Crit. Care Med. |volume=165 |issue=2 |pages=277–304 |date=January 2002 |pmid=11790668 |doi=10.1164/ajrccm.165.2.ats01 |url=}}</ref>
*This classification divides Idiopathic interstitial pneumonias into 7 clinicopathological entities.
*This classification divides Idiopathic interstitial pneumonias into 7 clinicopathological entities.
**Idiopathic pulmonary fibrosis (IPF)
**[[Idiopathic pulmonary fibrosis]] (IPF)
**Nonspecific interstitial pneumonia (NSIP)
**[[Nonspecific interstitial pneumonia]] (NSIP)
**Respiratory bronchiolitis-associated interstitial lung disease
**[[Respiratory bronchiolitis-interstitial lung disease|Respiratory bronchiolitis-associated interstitial lung disease]]
**Respiratory bronchiolitis-associated lung disease/desquamative interstitial pneumonia
**[[Desquamative interstitial pneumonia|Respiratory bronchiolitis-associated lung disease/desquamative interstitial pneumonia]]
**Cryptogenic organizing pneumonia
**[[Cryptogenic organizing pneumonia]]
**Acute interstitial pneumonia
**[[Hamman-Rich syndrome|Acute interstitial pneumonia]]
**lymphocytic interstitial pneumonia (LIP)
**[[Lymphocytic interstitial pneumonia]] (LIP)
 
 





Revision as of 20:55, 21 March 2018

Hamman-Rich syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hamman-Rich syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hamman-Rich syndrome classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hamman-Rich syndrome classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hamman-Rich syndrome classification

CDC on Hamman-Rich syndrome classification

Hamman-Rich syndrome classification in the news

Blogs on Hamman-Rich syndrome classification

Directions to Hospitals Treating Hamman-Rich syndrome

Risk calculators and risk factors for Hamman-Rich syndrome classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chandrakala Yannam, MD [2]

Overview

There is no established system for the classification of [disease name].

OR

[Disease name] may be classified according to [classification method] into [number] subtypes/groups: [group1], [group2], [group3], and [group4].

OR

[Disease name] may be classified into [large number > 6] subtypes based on [classification method 1], [classification method 2], and [classification method 3]. [Disease name] may be classified into several subtypes based on [classification method 1], [classification method 2], and [classification method 3].

OR

Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.

OR

If the staging system involves specific and characteristic findings and features: According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].

OR

The staging of [malignancy name] is based on the [staging system].

OR

There is no established system for the staging of [malignancy name].

Classification




References

  1. "American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001". Am. J. Respir. Crit. Care Med. 165 (2): 277–304. January 2002. doi:10.1164/ajrccm.165.2.ats01. PMID 11790668.

Template:WH Template:WS